Understanding the drug delivery through nails: a comprehensive review
Abstract
The nail unit is the largest cutaneous musculo-skeletal appendage. The management of nail disorders is an onerous task owing to the disease manifestations and anatomical structure of the nail plate. The topical treatment of nail infections/disorders has been a centerpiece of nail research in the past few decades as it offers a much safer and focused alternative to conventional oral therapy. However, transungual delivery had its challenges. This necessitated a lookout for novel approaches that enhanced treatment efficacy and reduced treatment time. Moreover, curing the nail condition using topical delivery has been challenging due to the lack of a validated animal model to determine the efficacy of the formulation and to establish a mathematical model that can help in predicting the desirable attributes of the formulation and permeation of various molecules through the nail plate. This review is based on publications retrieved by a selective search in PubMed. The purpose of this review is to provide an overview of nail anatomy and its disorders, factors affecting nail delivery, diagnostic procedures, current approaches, and promising approaches to treat nail infections/disorders including nail lacquers and the role of permeation enhancers, in-vitro models. This review also covers current available treatments and treatments under clinical trial.
Keywords: Musculo-skeletal, Nail infection, Transungual, Mathematical model, In-vitro models.
Keywords:
Musculo-skeletal, Nail infection, Transungual, Mathematical model, In-vitro modelsDOI
https://doi.org/10.22270/jddt.v11i4.4941References
Haneke E. Anatomy of the nail unit and the nail biopsy. , 34, 2. 2015; 34(2):95-100. DOI: 10.12788/j.sder.2015.0143
Wollina U, Nenoff P, Haroske G, Haenssle HA. The diagnosis and treatment of nail disorders. Deutsches Ärzteblatt International. 2016; 113(29-30):509. DOI: 10.3238/arztebl.2016.0509
Baswan S, Kasting GB, Li SK, et al. Understanding the formidable nail barrier: a review of the nail microstructure, composition and diseases. Mycoses. 2017; 60(5):284-295. https://doi.org/10.1111/myc.12592
Murthy SN, Maibach HI. Topical nail products and ungual drug delivery: CRC press; 2012. https://doi.org/10.1201/b12896
Bronaugh R, Maibach H. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms. Methodology. Taylor & Francis, Boca Raton. 2005. https://doi.org/10.1201/9780849359033.ch45
Chouhan P, Saini T. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers. International journal of pharmaceutics. 2012; 436(1-2):179-182. https://doi.org/10.1016/j.ijpharm.2012.06.020
Verma NK, Code Q. Advance development and current challenges in nails drug delivery-A Review. https://dx.doi.org/10.7439/ijap.v6i1.3934
Vikas A, Rashmin P, Mrunali P, Chavan RB, Kaushik T. Mechanistic insights of formulation approaches for the treatment of nail infection: conventional and novel drug delivery approaches. AAPS PharmSciTech. 2020; 21(2):1-12.
Fernández-Campos F, Navarro F, Corrales A, et al. Transungual Delivery, Anti-Inflammatory Activity, and In Vivo Assessment of a Cyclodextrin Polypseudorotaxanes Nail Lacquer. Pharmaceutics. 2020; 12(8):730. https://doi.org/10.3390/pharmaceutics12080730
Tampucci S, Terreni E, Zucchetti E, Burgalassi S, Chetoni P, Monti D. Formulations based on natural ingredients for the treatment of nail diseases. Current pharmaceutical design. 2020; 26(5):556-565. https://doi.org/10.2174/1381612826666200122150248
Rigopoulos D. Anatomy and physiology of the nail unit. Nail Therapies: Current Clinical Practice. 2021:1. https://doi.org/10.1201/9781003159117-1-1
Haneke E. Histopathology of the nail: onychopathology. 2017. https://doi.org/10.1201/9781315184005
Rigopoulos D. Acute paronychia. Nail Therapies: Current Clinical Practice. 2021:10. https://doi.org/10.1201/9781003159117
Schwartz CT, Ezaldein HH, Merati M. Ultraviolet Light Gel Manicures: Is There a Risk of Skin Cancer on the Hands and Nails of Young Adults? The Journal of Clinical and Aesthetic Dermatology. 2020; 13(7):45.
Murdan S. Drug delivery to the nail following topical application. International journal of pharmaceutics. 2002; 236(1-2):1-26. https://doi.org/10.1016/S0378-5173(01)00989-9
Cecchini A, Montella A, Ena P, Meloni GB, Mazzarello V. Ultrasound anatomy of normal nails unit with 18 mhz linear transducer. Italian journal of anatomy and embryology= Archivio italiano di anatomia ed embriologia. 2009; 114(4):137-144.
Farren L, Shayler S, Ennos A. The fracture properties and mechanical design of human fingernails. Journal of Experimental Biology. 2004; 207(5):735-741. https://doi.org/10.1242/jeb.00814
Rubin AI, Daniel CR. Simple Onycholysis and the Disappearing Nail Bed. Scher and Daniel’s Nails: Springer; 2018:227-232. https://doi.org/10.1007/978-3-319-65649-6_14
Starace M, Alessandrini A, Piraccini BM. Yellow Nail Syndrome. Therapies for Nail Disorders: CRC Press; 2020:168-176. https://doi.org/10.1201/9780429428012-26
Kamrani P, Pillarisetty LS. Anatomy, Bony Pelvis and Lower Limb, Toe Nails. 2019.
Muddasani S, Lin G, Hooper J, Sloan SB. Nutrition and Nail Disease. Clinics in Dermatology. 2021. https://doi.org/10.1016/j.clindermatol.2021.05.009
Shanbhag PP, Jani U. Drug delivery through nails: Present and future. New horizons in Translational Medicine. 2017; 3(5):252-263. https://doi.org/10.1016/j.nhtm.2017.01.002
Alavi A, Woo K, Sibbald RG. Common nail disorders and fungal infections. Advances in skin & wound care. 2007; 20(6):346-357. doi: 10.1097/01.ASW.0000276409.53632.42
Lipner SR. Nail Disorders: Diagnosis and Management. Dermatologic Clinics. 2021;39(2):xi. https://doi.org/10.1016/j.det.2021.01.002
Singh G, Haneef NS, Uday A. Nail changes and disorders among the elderly. Indian Journal of Dermatology, Venereology, and Leprology. 2005; 71(6):386. DOI: 10.4103/0378-6323.18941
Khanna S, Bajaj R, Khurana B, Srivastava K. Pharmacotherapeutic principles of ungual drug delivery system. Int J Drug Dev Res. 2012; 3:9-18.
Rajendra VB, Baro A, Kumari A, Dhamecha DL, Lahoti SR, Shelke SD. Transungual drug delivery: an overview. J Appl Pharm Sci. 2012; 2(1):203-209.
Poornima G, Sandhya Rani K. Nail drug delivery system-A novel approaches for drug delivery system. International Journal of Advanced Pharmaceutics. 2013; 3(2):102-109.
Kiran RS, Shekar BC, Vishnu P, Prasad M. Ungual drug delivery system of ketoconazole nail lacquer. Int J Appl Pharm. 2010; 4:17-19.
Jain G, Patel R. A comprehensive review on Transdermal drug delivery. International Journal of Pharmacy & Life Sciences. 2019;10.
Muralidhar P, Bhargav E, Reddy KR. Transungual Drug Delivery: An Over View. Int J Pharma Res Health Sci. 2017; 5(1):1522-1528. DOI:10.21276/ijprhs.2017.01.01
Mathew F, Bindumol K, Paul J, Pathadan RP, Varghese V. Understanding our natural nail-Antifungal agents. Int J Pharm Pharm Sci. 2014; 6(2).
Patil PS, Badgujar S, Torne A. Nailing the nail trouble by transungal drug delivery. Eur J Pharma Med Res. 2015; 2(2):551-571.
Palliyil B, Lebo DB. A novel transungual formulation (nail patch) for delivery of ciclopirox olamine into the nail and the nail folds. Int. J. Pharma Med. Biol. Sci. 2014; 3(3):13.
Khan AD, Giri A, Singh L. Transungual drug delivery: a newer approach. World J Pharmac. Pharmac Sci. 2014; 3(3):781-794.
Ohn J, Hur K, Park H, Cho S, Mun J. Dermoscopic patterns of green nail syndrome. Journal of the European Academy of Dermatology and Venereology: JEADV. 2021. DOI: 10.1111/jdv.17224
Rathi AR, Popat RR, Adhao VS, Shrikhande VN. Nail drug delivery system a review. International Journal of Pharmaceutical Chemistry and Analysis. 2020; 7(1):9-21. https://doi.org/10.18231/j.ijpca.2020.002
Turner R, Weaver S, Caserta F, Brown MB. A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis. International journal of pharmaceutical compounding. 2016; 20(1):71-80.
Samyuktha Metta DK. Development and Evaluation of a Novel Transungual Formulation (Nail Patch) for the Treatment of Onychomycosis. 2018.
Murthy SN, Waddell DC, Shivakumar H, Balaji A, Bowers CP. Iontophoretic permselective property of human nail. Journal of dermatological science. 2007; 46(2):150-152. https://doi.org/10.1016/j.jdermsci.2006.12.010
Arrese JE, Piérard GE. Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology. 2003; 207(3):255-260. https://doi.org/10.1159/000073086
Rich P. Principles and overview of nail surgery.
Grover C, Nanda S, Reddy BSN, Chaturvedi KU. Nail biopsy: assessment of indications and outcome. Dermatologic surgery. 2005; 31(2):190-194. https://doi.org/10.1111/j.1524-4725.2005.31042
Grover C, Reddy B, Uma Chaturvedi K. Diagnosis of nail psoriasis: importance of biopsy and histopathology. British Journal of Dermatology. 2005; 153(6):1153-1158. https://doi.org/10.1111/j.1365-2133.2005.06862.x
Liaquat S, Bryson A, Mochel M. Examination Of Nail Clippings For Onychomycosis: Histologic Observations With Microbiologic Correlations. American Journal of Clinical Pathology. 2020; 154(Supplement_1):S42-S42.
Grover C, Bansal S. Nail biopsy: A user's manual. Indian dermatology online journal. 2018; 9(1):3. DOI: 10.4103/idoj.IDOJ_268_17
Reilly I. Toenail surgery: Indications, options and techniques. Dermatological Nursing. 2021;20(1).
Grover C, Bansal S, Nanda S, Reddy B, Kumar V. En bloc excision of proximal nail fold for treatment of chronic paronychia. Dermatologic surgery. 2006; 32(3):393-399. https://doi.org/10.1111/j.1524-4725.2006.32079.x
Lee KJ, Kim JE, Ahn HS, Lee YB, Park HJ, Cho BK. Proximal nail fold-Lunula double punch technique: A Less-invasive method for sampling nail matrix (초). 프로그램북 (구 초록집). 2010; 62(1):218-218.
Grover C, Khandpur S, Nagi Reddy BS, Uma Chaturvedi K. Longitudinal nail biopsy: utility in 20‐nail dystrophy. Dermatologic surgery. 2003; 29(11):1125-1129. https://doi.org/10.1046/j.1524-4725.2003.29351.x
Aydin SZ, Ash Z, Del Galdo F, et al. Optical coherence tomography: a new tool to assess nail disease in psoriasis? Dermatology. 2011; 222(4):311-313. https://doi.org/10.1159/000329434
Bizheva K, Považay B, Hermann B, et al. Compact, broad-bandwidth fiber laser for sub-2-µm axial resolution optical coherence tomography in the 1300-nm wavelength region. Optics letters. 2003; 28(9):707-709. https://doi.org/10.1364/OL.28.000707
Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nature biotechnology. 2003;21(11):1361-1367. https://doi.org/10.1038/nbt892
Serup J, Jemec GB, Grove GL. Handbook of non-invasive methods and the skin: CRC press; 2006. https://doi.org/10.3109/9781420003307
Sattler E, Kaestle R, Rothmund G, Welzel J. Confocal laser scanning microscopy, optical coherence tomography and transonychial water loss for in vivo investigation of nails. British Journal of Dermatology. 2012; 166(4):740-746. https://doi.org/10.1111/j.1365-2133.2011.10730.x
Mogensen M, Thomsen JB, Skovgaard L, Jemec G. Nail thickness measurements using optical coherence tomography and 20‐MHz ultrasonography. British Journal of Dermatology. 2007; 157(5):894-900. https://doi.org/10.1111/j.1365-2133.2007.08118.x
Brown M, Turner R, Wevrett SR. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders. Expert opinion on drug delivery. 2018; 15(10):983-989. https://doi.org/10.1080/17425247.2018.1518425
Kushwaha A, Murthy RN, Murthy SN, Elkeeb R, Hui X, Maibach HI. Emerging therapies for the treatment of ungual onychomycosis. Drug development and industrial pharmacy. 2015; 41(10):1575-1581. https://doi.org/10.3109/03639045.2015.1033426
Luiza Ribeiro de Souza A, Priscila Kiill C, Kolenyak dos Santos F, et al. Nanotechnology-based drug delivery systems for dermatomycosis treatment. Current Nanoscience. 2012; 8(4):512-519. https://doi.org/10.2174/157341312801784311
Soliman GM. Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. International journal of pharmaceutics. 2017; 523(1):15-32. https://doi.org/10.1016/j.ijpharm.2017.03.019
Kumar S, Talegaonkar S, Negi LM, Khan ZI. Design and development of ciclopirox topical nanoemulsion gel for the treatment of subungual onychomycosis. Indian Journal of Pharmaceutical Education and Research. 2012; 46(4):303-311.
Tanrıverdi ST, Özer Ö. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis. European Journal of Pharmaceutical Sciences. 2013; 48(4-5):628-636. https://doi.org/10.1016/j.ejps.2012.12.014
Tuncay Tanrıverdi S, Hilmioğlu Polat S, Yeşim Metin D, Kandiloğlu G, Özer Ö. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation. Journal of liposome research. 2016; 26(2):163-173. https://doi.org/10.3109/08982104.2015.1067892
Bsieso EA, Nasr M, Moftah NH, Sammour OA, Abd El Gawad NA. Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine. 2015; 10(13):2017-2031. https://doi.org/10.2217/nnm.15.49
Bseiso EA, Nasr M, Sammour OA, Abd El Gawad NA. Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis. Drug delivery. 2016; 23(8):2813-2819. https://doi.org/10.3109/10717544.2015.1099059
Shukla T, Upmanyu N, Agrawal M, Saraf S, Saraf S, Alexander A. Biomedical applications of microemulsion through dermal and transdermal route. Biomedicine & Pharmacotherapy. 2018; 108:1477-1494. https://doi.org/10.1016/j.biopha.2018.10.021
Barot BS, Parejiya PB, Patel HK, Gohel MC, Shelat PK. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. Aaps Pharmscitech. 2012; 13(1):184-192. https://doi.org/10.1208/s12249-011-9742-7
Kansagra H, Mallick S. Microemulsion-based antifungal gel of luliconazole for dermatophyte infections: formulation, characterization and efficacy studies. Journal of Pharmaceutical Investigation. 2016; 46(1):21-28. DOI 10.1007/s40005-015-0209-9
Yadav U, Prajapati S, Prajapati R, Singh R. Development, optimization and characterization of topical nanoemulsion gel of an antifungual agent for effective treatment of onychomycosis. Pharma Research Library. 2015; 2:25-36.
Barot BS, Parejiya PB, Patel HK, Mehta DM, Shelat PK. Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies. Drug delivery and translational research. 2012; 2(6):463-476. DOI 10.1007/s13346-012-0109-8
Bhowmik D, Gopinath H, Kumar BP, Duraivel S, Aravind G, Kumar KS. Nail Drug Delivery System-A Novel Approaches For Drug Delivery System. The pharma innovation. 2013; 1(11, Part A):3.
Gaddime Sonali B, Nagoba S, Pattewar Shraddha G, Wadulkar R, Thonte S. Formulation and Evaluation of Medicated Nail Patches for the Treatment of Onychomycosis.
Hao J, Li SK. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. Journal of pharmaceutical sciences. 2008; 97(2):893-905. https://doi.org/10.1002/jps.21025
Elkeeb R, AliKhan A, Elkeeb L, Hui X, Maibach HI. Transungual drug delivery: current status. International journal of pharmaceutics. 2010; 384(1-2):1-8. https://doi.org/10.1016/j.ijpharm.2009.10.002
Shemer A. 9c (iii) Onychomycosis and Iontophoresis. Onychomycosis: Diagnosis and Effective Management. 2018:141. DOI:10.1002/9781119226512
Yim E, Falto‐Aizpurua LA, Ledon J, Nouri K. Lasers and Lights for Onychomycosis. Pediatric Dermatologic Surgery. 2019:229-240. https://doi.org/10.1002/9781118769836.ch21
Hao J, Li SK. Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength. Journal of pharmaceutical sciences. 2008; 97(12):5186-5197. https://doi.org/10.1002/jps.21368
Mididoddi PK, Repka MA. Characterization of hot-melt extruded drug delivery systems for onychomycosis. European Journal of Pharmaceutics and Biopharmaceutics. 2007; 66(1):95-105. https://doi.org/10.1016/j.ejpb.2006.08.013
Repka MA, O'Haver J, See CH, Gutta K, Munjal M. Nail morphology studies as assessments for onychomycosis treatment modalities. International journal of pharmaceutics. 2002; 245(1-2):25-36. https://doi.org/10.1016/S0378-5173(02)00321-6
Basini P, Kr DB, Sudip D, Subhas S. Nail drug delivery system: a review. Journal of advanced Pharmacy education & research. 2012; 2(3):101-109.
Torkar A, Kristl J, Murdan S. Low-frequency ultrasound to enhance topical drug delivery to the nail. 2007.
Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Advanced drug delivery reviews. 2004; 56(5):589-601. https://doi.org/10.1016/j.addr.2003.10.024
Karell ML. Laser apparatus for making holes and etchings: Google Patents; 1999.
Saner MV, Kulkarni AD, Pardeshi CV. Insights into drug delivery across the nail plate barrier. Journal of drug targeting. 2014;2 2(9):769-789. https://doi.org/10.3109/1061186X.2014.929138
Donnelly RF, McCarron PA, Lightowler JM, Woolfson AD. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. Journal of controlled release. 2005; 103(2):381-392. https://doi.org/10.1016/j.jconrel.2004.12.005
Malhotra GG, Zatz JL. Investigation of nail permeation enhancement by chemical modification using water as a probe. Journal of pharmaceutical sciences. 2002; 91(2):312-323. https://doi.org/10.1002/jps.10058
Murdan S. Enhancing the nail permeability of topically applied drugs. Expert opinion on drug delivery. 2008; 5(11):1267-1282. https://doi.org/10.1517/17425240802497218
Quintanar-Guerrero D, Ganem-Quintanar A, Tapia-Olguin P, Kalia YN, Buri P. The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail. Drug development and industrial pharmacy. 1998; 24(7):685-690. https://doi.org/10.3109/03639049809082373
WALTERS KA, FLYNN GL, MARVEL JR. Physicochemical characterization of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum. Journal of Pharmacy and Pharmacology. 1983; 35(1):28-33. https://doi.org/10.1111/j.2042-7158.1983.tb04258.x
Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone M, Mailland F. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. Drug development and industrial pharmacy. 2005; 31(1):11-17. https://doi.org/10.1081/DDC-43935
Baran R, Tosti A. Chemical avulsion with urea nail lacquer. Journal of dermatological treatment. 2002; 13(4):161-164. https://doi.org/10.1080/09546630212345672
Morganti F, Bramanti E, Solaro R, et al. Thermal and spectroscopic characterization of interactions between 2-nonyl-1, 3-dioxolane and stratum corneum components. Journal of bioactive and compatible polymers. 1999; 14(2):162-177. https://doi.org/10.1177%2F088391159901400205
Hui X, Chan TC, Barbadillo S, Lee C, Maibach HI, Wester RC. Enhanced econazole penetration into human nail by 2‐n‐nonyl‐1, 3‐dioxolane. Journal of pharmaceutical sciences. 2003; 92(1):142-148. https://doi.org/10.1002/jps.10291
Nair AB, Sammeta SM, Vaka SRK, Murthy SN. A study on the effect of inorganic salts in transungual drug delivery of terbinafine. Journal of Pharmacy and Pharmacology. 2009; 61(4):431-437. https://doi.org/10.1211/jpp.61.04.0003
Aggarwal R, Targhotra M, Kumar B, Sahoo P, Chauhan MK. Novel Polypseudorotaxanes Hydrogel based Nail Lacquer of Efinaconazole for Transungual Drug Delivery. Drug Delivery Letters. 2021; 11(1):52-61. https://doi.org/10.2174/2210303110999200918163213
Shivakumar H, Repka M, Murthy SN. Transungual drug delivery: an update. Journal of Drug Delivery Science and Technology. 2014; 24(3):301-310. https://doi.org/10.1016/S1773-2247(14)50049-4
Maibach HI, Luo EC, Hsu T-m. Topical administration of basic antifungal compositions to treat fungal infections of the nails: Google Patents; 2005.
Jagat S, McKay D. Topical nail formulation: Google Patents; 2009.
Müller-Goymann C. Formulation for nail and nail bed diseases: Google Patents; 2012.
Riley L. Topical formulation for treating fingernails and toenails: Google Patents; 2007.
Chaudhuri B, Chim MF, Bucks D. Topical formulations for the treatment of nail fungal diseases: Google Patents; 2000.
Meyer H. Pharmaceutical and cosmetic formulations for treating fingernails: Google Patents; 2007.
Quan D, Ruiz A. Nail compositions and methods of administering same: Google Patents; 2003.
Nimni M. Anti-fungal nail lacquer and method therefor: Google Patents; 1996.
Barrett JR, Brennan JJ, Patton TP. Formulation and method for the treatment of fungal nail infections: Google Patents; 2016.
Cevc G, Vierl U. Topical terbinafine formulations and methods of administering same for the treatment of fungal infections: Google Patents; 2010.
Zhang J, Warner KS, Kumar P, Aliyar H. Systems, methods, and formulations for topically treating nail fungal infections and nail psoriasis: Google Patents; 2009.
Kepka SW, Mo YJ, Wang H-y, Lu M, Pfister WR. Antifungal nail coat and method of use: Google Patents; 2008.
Etheredge RW, Goldberg DI, Davis SP, Chakraborty B, Barsness MS. Method and system for treating of onychomycosis with an applicator having a gel medicament layer: Google Patents; 2008.
Sakamoto M, Sugimoto N, Kawabata H, et al. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails. Journal of drugs in dermatology: JDD. 2014; 13(11):1388-1392.
Gupta AK, Simpson FC. New pharmacotherapy for the treatment of onychomycosis: an update. Expert opinion on pharmacotherapy. 2015; 16(2):227-236. https://doi.org/10.1517/14656566.2015.993380
Gupta AK, Studholme C. Novel investigational therapies for onychomycosis: an update. Expert opinion on investigational drugs. 2016; 25(3):297-305. https://doi.org/10.1517/13543784.2016.1142529
Published
Abstract Display: 1433 
PDF Downloads: 1598 PDF Downloads: 816 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.